“Phage use can help modulate the respiratory virome & microbiome and can have important implications for asthma management”

September 2019 | Interview

Interviewee: Dr George Guibas, Member of the Ethics Advisory Board of CURE, Clinician Specialist in Allergy.


Interviewer: Sofia Romagosa Vilarnau, Junior Projects and Engagement Officer at the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA)



Amazing news: our partner BRFAA is nominated for the 2019 Innovation Radar Prize of the EU Commission for its high-quality and innovative research on phage therapy for CURE!



“I am a strong believer in the potential of phage therapies”

May 2019 | Interview

Interviewee: Prof. Dr. Johan Garssen, Member of the Scientific Advisory Board of CURE, is an Immunologist with a big experience in immune-microbiome interactions. He is Head of Immunopharmacology in the Division of Pharmaceutical Sciences in Utrecht University as well as the Director of the Immunology platform at Danone/Nutricia-research for specialised nutrition.


Interviewer: Sofia Romagosa Vilarnau, Junior Projects and Engagement Officer at the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA)



Nikos Papadopoulos, CURE Coordinator


to the exciting world of CURE!

Did you know that there are 30 million Europeans suffering from asthma and that its control remains suboptimal despite treatment?
Despite recent advances in research, a cure for asthma is still far from reality, and patients still need new treatment approaches to better manage the disease.

CURE in brief

CURE, a research project funded by the EU programme Horizon 2020, proposes a phage therapy to rebalance the structure of the microbiome in the airways, with the hypothesis that this may also control the immune dysregulation of asthma and eventually even cure it.

Highlights from Tbilisi

On September 24th 2018 the George Eliava Institute of Bacteriophage, Microbiology and Virology in Tbilisi, Georgia, hosted the 1st partner meeting of the CURE project after the kick-off meeting held in Greece in 2017.
A lot of progress has been made during the first year of project and really interesting results were presented in the meeting.

6 work packages, 9 partners, 1 objective: set the ground to find a way to cure asthma

The CURE project is structured in 6 work packages addressing current challenges and bottlenecks that need to be surpassed to take our hypothesis forward.

"We would like to show the effect of bacteriophages on the immune system"

November 2018 | Interview

Interviewee:  Professor Mübeccel Akdis, head of the Immune dermatology department at the Swiss Institute of Allergy and Asthma Research (SIAF)


Interviewer: Giuseppe De Carlo, Director of Operations and Projects at the European Federation of Allergy and Airways Diseases (EFA)



“All researchers working on asthma should explore completely novel ways to tackle asthma and to prevent it”.

3 May, 2018 | Interview

Interviewee: Nikos Papadopoulos, Professor at the National and Kapodistrian University of Athens

Interviewer: Isabel Proaño, Communications Manager at the European Federation of Allergies and Airways Diseases Patients’ Associations (EFA)

Kick-off Meeting

2 October, 2017 | Event

CURE project officially started on 1st of October 2017. The launch meeting took place in Athens.

© 2017 Cure. Eubiosis Reinstatement Therapy

  • Twitter Social Icon






This project has received funding from the European Union’s Horizon 2020 research

and innovation programme under grant agreement No 767015.

The content of this website reflects only the views of its authors.

The European Commission is not responsible for any use that may be made of the information it contains